Amylyx Pharmaceuticals, Inc. AMLX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s accounts payable?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported accounts payable of $3.53M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s accounts payable changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s accounts payable decreased by 26.6% year-over-year, from $4.81M to $3.53M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s accounts payable?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s accounts payable has grown at a 46.8% compound annual growth rate (CAGR), from $3.66M to $16.96M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.